MAY COULD be considered the month of penitence. It was the month that Big Pharma appear to have discovered its conscience if, indeed, that's what it was. Two initiatives were announced to address the health needs of the world's poorest countries: one, by Pfizer at the World Economic Forum in Davos and another, by a group of other large pharma companies which joined hands with global health organisations at a side-event of the World Health Assembly in Geneva. Both are aimed at improving global health equity.
Pfizer, by far the world's top revenue earner thanks to its COVID-19 vaccine Comirnaty, launched an extensive "Accord for a Healthier World" project. The US drug giant promises to provide all of its patented, high-quality medicines and vaccines available in the US and the European Union on a not-for-profit basis to people in 45 lower-income countries. The company "seeks to greatly reduce the health inequities that exist between many lower-income countries and the rest of the world".
Comirnaty, described as the fastest-selling drug in pharma history, contributed the bulk of Pfizer's sales of $72 billion last year, and a reason why it has faced constant flak from the public health groups. They say the company has not done enough to help poor countries during the worst of the pandemic (see 'Calling out Albert Bourla and Big Pharma', Down To Earth, 16-31 January 2022) and provide access to lifesaving medicines. Did the worldwide censure, despite the honours and market accolades the company has earned for developing Comirnaty in a short span, prompt Pfizer to come up with this seemingly generous project? Perhaps, it did; beyond the market is a company reputation and that has been undeniably dented.
هذه القصة مأخوذة من طبعة June 16, 2022 من Down To Earth.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك ? تسجيل الدخول
هذه القصة مأخوذة من طبعة June 16, 2022 من Down To Earth.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك? تسجيل الدخول
In leading role again
MOVIES AND WEB SERIES ARE ONCE AGAIN BEING SET IN RUSTIC BACKGROUNDS, INDICATING A RECONNECT BETWEEN CINEMA AND THE COUNTRYSIDE
One Nation One Subscription comes at a huge cost
As top US universities scrap big deals with top scientific publishers, India’s ONOS scheme seems flawed and outdated
Return of Rambhog
Bid to revive and sell the aromatic indigenous paddy variety has led to substantial profits for farmers in Uttar Pradesh's Terai region
Scarred by mining
Natural springs of Kashmir drying up due to illegal riverbed mining
Human-to-human spread a mutation away
CANADA IN mid-November confirmed its first human case of avian influenza, with a teenager in the British Columbia being hospitalised after contracting the H5N1 virus that causes the disease. The patient developed a severe form of the disease, also called bird flu, and had respiratory issues. There was no known cause of transmission.
True rehabilitation
Residents of Madhya Pradesh's Kakdi village take relocation as an opportunity to undertake afforestation, develop sustainable practices
INESCAPABLE THREAT
Chemical pollution is the most underrated and underreported risk of the 21st century that threatens all species and regions
THAT NIGHT, 40 YEARS AGO
Bhopal gas disaster is a tragedy that people continue to face
A JOKE, INDEED
A CONFERENCE OF IRRESPONSIBLE PARTIES THAT CREATED AN OPTICAL ILLUSION TO THE REALITY OF A NEW CLIMATE
THINGS FALL APART
THE WORLD HAS MADE PROGRESS IN MITIGATING EMISSIONS AND ADAPTING TO CLIMATE IMPACTS. BUT THE PROGRESS REMAINS GROSSLY INADEQUATE